Measures of dopamine transporter (DAT) activity in the nigrostriatal and mesolimbic systems in patients in the early phases of PD has unraveled initially more prominent neurodegeneration in dopamine nerve terminals and axons and less severe in the substantia nigra (Caminiti et al., 2017). Here, SLC6A3 is linked to Parkinson disease.